Public data, as of October 2026

Company profile

Novo Nordisk A/S

NVOnovonordisk.comLatest disclosure 2024

Novo Nordisk A/S reported about 2.3 million tCO₂e for 2024, and 96% of it sits in Scope 3, in the value chain beyond the company's own operations.

Is this your company? Claim it

SBTi statusValidated Targets

Near-term status: Validated Targets. Net-zero status: Validated Targets.

Where insetting fits

Scope 3 is 96% of the footprint, the part of the value chain that supplier emissions reductions can reach.

Peer position

Scope 3 is 96% of the footprint, above the peer median of 91%.

Voluntary retirements

Registry records show 2 credits retired for this company.

Emissions

How the reported footprint breaks down by scope and year.

Peer benchmark

How Novo Nordisk A/S compares with its industry peers on Scope 3.

Peers: companies in the SBTi industry "Pharmaceuticals, Biotechnology and Life Sciences", by Scope 3 share of the latest reported footprint.

CompanyScope 3 share%

Novo Nordisk A/SThis company96%
McKesson Corporation99%

Company profile

A claimed profile keeps the figures accurate and shows the company’s projects.

Claiming is free. Your team can correct data, add newer disclosures and list reduction projects from your value chain, so that customers and suppliers can co-fund them.

Claim this profile Talk to Carbon3

1
Confirm employment at the company

Related projects

8 listed

Inset projects on Carbon3None yet

tCO₂e, GHG Protocol scopes
Source: published disclosure, FY2024

Reported emissions by year

Scope 1
Scope 2
Scope 3

FY2024

Scope 1, direct	85,0004%
Scope 2, purchased energy	16,0001%
Scope 3, value chain	2,160,00096%
Total	2,261,000

Years without a matched disclosure stay open until a published source is matched.

Source document: novonordisk.com

Scope 3 by category, 2024

9 categories itemized

C1Purchased Goods and ServicesLargest category1.2 Mt56%
C2Capital Goods465 kt22%
C3Fuel and Energy Related Activities74 kt3%
C4Upstream Transportation and Distribution101 kt5%
C5Waste Generated in Operations6 kt<1%
C6Business Travel188 kt9%
C7Employee Commuting52 kt2%
C9Downstream Transportation and Distribution57 kt3%
C12End-of-Life Treatment of Sold Products2 kt<1%

Climate targets

What the SBTi listing says about the company's targets.

Status as published by the SBTi

Primary SBTi record: Novo Nordisk A/S

Near-term targetValidated Targets

Classification: 1.5°C
Target year: 2033

Net-zero targetValidated Targets

Net-zero year: 2045

Carbon3 shows each record exactly as the SBTi publishes it, and does not assess, rate or endorse targets. A validated target says nothing about any market instrument.

Voluntary retirements

Voluntary credits retired for this company on public registries.

Registry records naming the company as beneficiary

ProjectRegistryRetired inCredits retired

Cookstove (GLD4364)Gold Standard20252

These are voluntary market retirements, which sit outside the value chain. Inset credits retired on Carbon3 would appear as their own rows, linked to the supplier project.2 credits in total

Bayer Aktiengesellschaft

74%

Thermo Fisher Scientific Inc.94%

Merck & Co., Inc.87%

AstraZeneca plc98%

Merck KGaA81%

Peer median: 91%Scope 3 boundaries differ between reports, so compare shares with care.

Scope 3 position

Above the peer median

The company's Scope 3 share is 96%, against a peer median of 91%.

Disclosure coverage

6 of 6 disclose

6 of 6 named peers report all three scopes, so their Scope 3 share can be compared.

Research summary

What the public record says about this company's decarbonization.

No report has been generated for this company yet

Anyone can read a cached company report, while generating a new one can take a few minutes and needs a free account.

Related projects

Decarbonization projects that name the company as a partner.

Emerging projects catalog, status as reported by each project

ProjectStatus

Replicative Approach to e-Methanol Production ScalingAnnounced
Sustainable Fuel Project at Copenhagen AirportAnnounced
Port of Hanstholm e-Methanol ProjectAnnounced
eSMR-MeOH: Biogas to MeOH by electric reformingOperational
REintegrate Green Methanol Production at GreenLab SkiveOperational
Reintegrate Greenlab SkiveUnder Development
eSMR Methanol demo plant in Aarhus UniversityOperational
Vordingborg BiofuelsAnnounced

Partner names are companies. The Data Hub never publishes personal contact details.View all related projects

No inset projects are listed for this company yet.

Suppliers to Novo Nordisk A/S can list a reduction project on Carbon3 at no cost, so that the company could co-fund it.

List a supplier project

Sign in with an email address at the company's own domain.

2

Review the data

Flag corrections and upload newer disclosures, which Carbon3 checks against a published source.

3

List a project at no cost

Turn verified supply-chain reductions into inset credits that partners can co-fund.

A free account also gives access to downloads, alerts and new research reports.